Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Laura Pérez-Ortega
Observed names:
José A. Pérez-Simón,
L. Pérez Ortega,
L. Pérez‐Ortega,
Laura Perez-Ortega,
Laura Pérez Ortega
Institutions:
Instituto de Biomedicina de Sevilla,
Hospital Universitario Virgen del Rocío,
Centro de Investigación Biomédica en Red de Cáncer,
Universidad de Sevilla
Observed institutions:
Consejo Superior de Investigaciones Científicas,
Instituto de Biomedicina de Sevilla,
Hospital Universitario Virgen del Rocío,
Centro de Investigación Biomédica en Red de Cáncer,
Universidad de Sevilla
ORCID:
0000-0001-8049-1716
Observed ORCID:
0000-0001-8049-1716
OpenAlex ID:
A5015936856
Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era
2023
·
Alberto Mussetti
, Leyre Bento
, et al.
·
Bone Marrow Transplantation
·
15
Next-generation BCMA-targeted chimeric antigen receptor CARTemis-1: the impact of manufacturing procedure on CAR T-cell features
2024
·
Belén Sierro-Martínez
, Virginia Escamilla-Gómez
, et al.
·
Cellular Oncology
·
5
PDF
Cytopenias in CAR-T Cell Therapy and Use of Transfusion Resources in Adult Patients with Lymphoproliferative Disorders
2021
·
Lucía Mezquita
, Maria Eva Mingot
, et al.
·
Blood
·
5
Nuclear protrusion in dysplastic micromegakaryocytes
2019
·
Laura Pérez-Ortega
, Rosario M. Morales-Camacho
·
Blood
·
2
PDF
Impact of inotuzumab ozogamicin as bridging therapy and tumor burden in CAR-T therapy for B-acute lymphoblastic leukemia
2025
·
Patricia Alcalde-Mellado
, Victoria Ruiz-Maldonado
, et al.
·
Frontiers in Immunology
·
1
PDF
Correction: Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era
2023
·
Alberto Mussetti
, Leyre Bento
, et al.
·
Bone Marrow Transplantation
·
1
PDF
Pediatric B-Cell Acute Lymphoblastic Leukemia: Comprehensive Genomic Characterization Including SNP-Array and Analysis of Relapse Risk
2026
·
Concepción Prats-Martín
, Laura Pérez Ortega
, et al.
·
Cancers
Comparative analysis of toxicity and efficacy of melphalan at doses of 140 mg/m2 VS. 200 mg/m2 as a conditioning regimen prior to autologous stem cell transplantation.
2025
·
Beatriz Chiclana-Rodríguez
, Marta García Culebras
, et al.
·
Blood
PDF
Adolescente de 13 años con bicitopenia y adenopatías
2025
·
Concepción Prats-Martín
, Elena Soria-Saldise
, et al.
·
Revista Sangre
PDF
New Optimized Academic Anti-BCMA CAR (CARTemis-1): How Does the Manufacturing Process Impact CAR-T Cell Features?
2023
·
Belén Sierro-Martínez
, Virginia Escamilla Gomez
, et al.
·
Blood
Role of Allogeneic Hematopoietic Cell Transplant for Relapsed/Refractory Large B-Cell Lymphomas in the CART Era
2022
·
Alberto Mussetti
, Leyre Bento
, et al.
·
Blood
Pb2215 How to Predict Response to Ruxolitinib in Patients With Myelofibrosis
2019
·
M.I. Montero
, M. Reinoso
, et al.
·
HemaSphere
Ps1080 Lymphoma Associated Hemophagocytic Syndrome: a Single‐center Experience
2019
·
J.A. Rojas Martínez
, C. Prats‐Martín
, et al.
·
HemaSphere
Show more works
View as search
Works count:
14
Citation count:
29
H-index:
3
I10-index:
1
Year
Topic
Type